ACE and diabetes mellitus: In one study, the addition of spironolactone or losartan to ACE inhibitor therapy in patients with hypertension, diabetes, and albuminuria was associated with significant increases in serum potassium level compared to the outcome in the placebo group (p < 0.0001 and p = 0.03, respectively) [94].